Pharmaceutical Research

Aims & Scope

Pharmaceutical Research, an official journal of the American Association of Pharmaceutical Scientists, is committed to publishing novel research that is mechanism-based, hypothesis-driven and addresses significant issues in drug discovery, development and regulation.

Current areas of interest include, but are not limited to: -(pre)formulation engineering and processing- computational biopharmaceutics- drug delivery and targeting- molecular biopharmaceutics and drug disposition (including cellular and molecular pharmacology)- pharmacokinetics, pharmacodynamics and pharmacogenetics.

Research may involve nonclinical and clinical studies, and utilize both in vitro and in vivo approaches.

Studies on small drug molecules, pharmaceutical solid materials (including biomaterials, polymers and nanoparticles) biotechnology products (including genes, peptides, proteins and vaccines), and genetically engineered cells are welcome.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	4.3
2024	3.50

SJR (SCImago Journal Rank)

Year	Value
2024	0.871

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	235

Journal Rank

Year	Value
2024	5988

Journal Citation Indicator

Year	Value
2024	2472

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Chemistry, Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability

  Citation: 4210

  Authors: Gordon L., Hans, Vinod P., John R.

• Physiological Parameters in Laboratory Animals and Humans

  Citation: 2591

  Authors: Brian, Tim

• Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date

  Citation: 2168

  Authors: Daniel, Kye J., Jiaul, Kristofer J., Simon R.

• Cancer is a Preventable Disease that Requires Major Lifestyle Changes

  Citation: 1650

  Authors: Preetha, Ajaikumar B., Chitra, Kuzhuvelil B., Sheeja T., Oiki S., Bokyung, Bharat B.

• Micellar Nanocarriers: Pharmaceutical Perspectives

  Citation: 1578

  Authors: V. P.

• Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein Aggregates

  Citation: 1540

  Authors: Vasco, Andrea, Wim

• Pharmaceutical Particle Engineering via Spray Drying

  Citation: 1391

  Authors: Reinhard

• Bioanalytical Method Validation—A Revisit with a Decade of Progress

  Citation: 1294

  Authors: Vinod P., Kamal K., John W. A., Howard M., James D., Iain J., Gordon, Krys J., Rabindra N., Mark L., Alfred, C. T., Avraham

• Predicting Skin Permeability

  Citation: 1286

  Authors: Russell O., Richard H.

• Physical Stability of Proteins in Aqueous Solution: Mechanism and Driving Forces in Nonnative Protein Aggregation

  Citation: 1212

  Authors: Eva Y., Sampathkumar, Theodore W., John F.

---